Citeline and ICON Biotech surveyed over 100 professionals to uncover their key pain points in the oncology drug development lifecycle, capturing the key challenges and future advancements hoping to accelerate patient treatments.
Explore a snapshot of key findings from the survey, including:
- Current therapies in the oncology pipeline
- Clinical vs therapeutic development challenges
- Latest strategies accelerating drug development
- The role of AI/ML in advancing R&D
- Emerging trends and predictions
Download the infographic: Advancing Drug Development in Oncology